Alan Nurden: One of The Best Articles That I Have Read in 2025
Alan Nurden, Emeritus Research Director at CNRS, shared on LinkedIn:
”One of the best articles that I have read in 2025.
The wide-ranging pathophysiology of RUNX1 mutations is clearly illustrated through a series of case reports where families were gentotyped using a NGS-based sequencing panel.
The association of platelet function defects, thrombocytopenia and malignancy risk is highlighted case by case in a thoroughly professional manner.
Highly recommended.”
Read the full article in Frontiers.
Article: RUNX1-FPDMM in families with mild thrombocytopenia and platelet function anomalies: a case series
Authors: Hannah Glonnegger, Doris Boeckelmann, Rebekka Wiedenhöfer, Wolf-Achim Hassenpflug, Tim Ripperger, Dirk Lebrecht, Ralf Knöfler, Oliver Tiebel, Udo Koehler, Claudia Wehr, Harry Sirb, Monika Sparber-Sauer, Katrin Reinsberger, Ayami Yoshimi, Brigitte Strahm, Barbara Zieger
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25